Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Managing the Risk of Hepatitis B Virus Reactivation in COVID-19 Patients Treated With Corticosteroids

NCT07154212 is registered in ClinicalTrials.gov with University Medical Centre Ljubljana as lead sponsor.

NCT NCT07154212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07154212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Managing the Risk of Hepatitis B Virus Reactivation in COVID-19 Patients Treated With Corticosteroids
Lead sponsor
University Medical Centre Ljubljana
Phase
Observational
Overall status
Completed
Start date
November 1, 2020
Completion date
April 8, 2022
Enrollment
1,793 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pneumonia, hepatitis b, hypoxemia